Influence of heparin and low molecular weight dextran on the patency of autogenous vein grafts in the venous system.

Ítems similars

• Low-molecular-weight heparins in the treatment of venous thromboembolism
  per: Ageno , Walter, et al.
  Publicat: (2000)
• Low-molecular-weight heparin and abciximab for thrombo-occlusive saphenous vein graft disease. Report of 2 cases.
  per: Yaryura, R, et al.
  Publicat: (1997)
• Unfractionated heparin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in trauma
  per: Jacobs, Benjamin N., et al.
  Publicat: (2017)
• Low-molecular-weight heparin in the treatment of deep venous thrombosis.
  per: Hauer, K E
  Publicat: (1998)
• Treatment of deep venous thrombosis with low molecular weight heparins.
  per: Ruiz, F, et al.
  Publicat: (1998)